Close

Goldman Sachs Downgrades Solid Biosciences (SLDB) to Sell

May 14, 2019 7:08 AM EDT Send to a Friend
Goldman Sachs analyst Salveen Richter downgraded Solid Biosciences (NASDAQ: SLDB) from Neutral to Sell ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login